Join Drs Michael Wechsler and Ian D. Pavord as they discuss the future of asthma care. Where will we be in 5 or even 10 years from now? What breakthroughs are on the horizon? Tune in to find out.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/987116). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Asthma https://emedicine.medscape.com/article/296301-overview

Type 2 Inflammation in Asthma and Other Airway Diseases https://pubmed.ncbi.nlm.nih.gov/35923421/

Considering Biomarkers in Asthma Disease Severity https://pubmed.ncbi.nlm.nih.gov/34942235/

Epithelial Cell Alarmin Cytokines: Frontline Mediators of the Asthma Inflammatory Response https://pubmed.ncbi.nlm.nih.gov/36311787/

Targeting TSLP in Asthma https://pubmed.ncbi.nlm.nih.gov/35685846/

The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms https://pubmed.ncbi.nlm.nih.gov/29593707/

NICE (National Institute for Health and Care Excellence) https://www.nice.org.uk/

Preventing Asthma in High Risk Kids (PARK) With Omalizumab: Design, Rationale, Methods, Lessons Learned and Adaptation https://pubmed.ncbi.nlm.nih.gov/33242697/

Mechanisms of Non–Type 2 Asthma https://pubmed.ncbi.nlm.nih.gov/33160187/

Effect of Azithromycin on Asthma Exacerbations and Quality of Life in Adults With Persistent Uncontrolled Asthma (AMAZES): A Randomised, Double-blind, Placebo-Controlled Trial https://pubmed.ncbi.nlm.nih.gov/28687413/

Bronchial Thermoplasty https://emedicine.medscape.com/article/2094272-overview

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network https://preciseasthma.org/preciseweb/

KIT Inhibition by Imatinib in Patients With Severe Refractory Asthma https://pubmed.ncbi.nlm.nih.gov/28514613/

JAK Inhibitors for Asthma https://pubmed.ncbi.nlm.nih.gov/34625142/

Optimizing Asthma Management: Role of Long-Acting Muscarinic Antagonists https://pubmed.ncbi.nlm.nih.gov/35933228/

Efficacy and Safety of Once-Daily Single-Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI in Patients With Inadequately Controlled Asthma (CAPTAIN): A Double-blind, Randomised, Phase 3A Trial https://pubmed.ncbi.nlm.nih.gov/32918892/

Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes https://pubmed.ncbi.nlm.nih.gov/35549845/

Claude Bernard, the Founder of Modern Medicine https://pubmed.ncbi.nlm.nih.gov/35626738/